Xcout Intel
PanTher Therapeutics, LLC
PanTher Therapeutics, LLC is a startup founded in 2014 and based in Austin, Texas, that develops drugs for pancreatic cancer.
Subscribe to see PanTher Therapeutics, LLC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
PanTher Therapeutics, LLC at a glance
PanTher Therapeutics, LLC is a therapeutics company headquartered in United States. It has raised at least $20.3M across the 9 funding rounds on record. Its most recent funding round, Series B, raised $3M in March 2025. Xcout tracks 6 named people at PanTher Therapeutics, LLC, including Laura Indolfi (President).
PanTher Therapeutics, LLC leadership
- Laura IndolfiPresident
- D MackeyDirector
- Daniel WildmanDirector
- Darshana ZaveriDirector
- Maria PalasisDirector
- Tim ClacksonBoard of Directors
PanTher Therapeutics, LLC funding rounds
At least $20.3M raised across the 9 rounds on record. The 4 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $3M | 2 named | |
| SEC Form D filing | $2.7M | — | |
| SEC Form D filing | $1.3M | — | |
| Grant | $5.4M | 2 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
PanTher Therapeutics, LLC competitors
A few of PanTher Therapeutics, LLC's closest competitors — see the full list of competitors and alternatives →
Shattuck Labs, Inc. operates as a biotechnology firm based in the United States, currently at the clinical development stage. Its core mission is to create innovative therapeutics designed to combat both cancer and autoimmune diseases. The company's leading experimental compound, SL-172154, is presently undergoing Phase 1 clinical assessment for the treatment of ovarian, fallopian tube, and peritoneal cancers. Furthermore, Shattuck Labs is advancing another product candidate, SL-279252, which is also in Phase 1 trials for patients afflicted with advanced solid tumors and lymphoma. Established in 2016, the company maintains its corporate headquarters in Austin, Texas.
Ollin Biosciences is a clinical-stage biopharmaceutical holding company established in 2023 and headquartered in Austin, Texas, dedicated to developing therapeutics.
Mati Therapeutics Inc. is a development-stage company headquartered in Austin, Texas, focused on developing therapeutic products.
Quanta Therapies is a biopharmaceutical company that develops allosteric small molecule inhibitors targeting RAS-driven cancers, such as pancreatic, colorectal, lung, and endometrial cancers. The company focuses on modulating RAS signaling at the cell membrane to treat previously undruggable mutations like KRAS G12D and KRAS G12V.
January Therapeutics, Inc. is a privately held biotechnology company founded in 2017 and based in California, focused on developing next-generation targeted anti-cancer therapies.
Plus Therapeutics, Inc. operates as a clinical-stage pharmaceutical company, dedicated to the development, manufacturing, and market introduction of therapeutic solutions for cancer patients and individuals with other serious illnesses. A cornerstone of their pipeline is Rhenium-186 NanoLiposome (R-186 NL), a patented radiotherapy specifically engineered to address difficult central nervous system (CNS) cancers, such as recurrent glioblastoma, leptomeningeal metastases, and various brain cancers affecting children. The company has also secured a licensing agreement with NanoTx, Corp. to advance and commercialize NanoTx's treatment for glioblastoma. Founded in 1996 and headquartered in Austin, Texas, the firm adopted its current name, Plus Therapeutics, Inc., in July 2019, having previously operated as Cytori Therapeutics, Inc.
Get PanTher Therapeutics, LLC's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on PanTher Therapeutics, LLC in Xcout Intel
- 6 named people with titles, LinkedIn and board committees
- 9 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access